Comparative effectiveness of dupilumab and JAK inhibitors in atopic dermatitis
Dose reduction compromises efficacy of JAK inhibitors-The CORNERSTONE study.
Wang R, Yang Z, Li H, Wang Y
Journal of the American Academy of DermatologyIn the feed 1 Aug 2026, published online 1 Aug 2026, issue 2026 Aug 01, added to PubMed 1 Aug 2026
Topics: Atopic dermatitis & eczemaBiologicsJAK inhibitors & other targeted pills
Abstract
PubMed has no abstract for this paper, as is usual for research letters, correspondence and editorials. The publisher’s page has the full paper.
PMID 42541509 · DOI 10.1016/j.jaad.2026.07.024